Home / Recalls / Rising Pharma Holding, Inc. / D-0222-2024

D-0222-2024 Class II Ongoing

Recalled by Rising Pharma Holding, Inc. — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
January 17, 2024
Initiation Date
December 29, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
47,976 bottles

Product Description

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

Reason for Recall

Presence of Foreign Tablets/Capsules

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: BPA123098A, Exp. Date 06/2025

Other recalls by Rising Pharma Holding, Inc.

  • D-0384-2026 Class II — Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx onl (March 3, 2026)
  • D-0029-2026 Class II — Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, (October 7, 2025)
  • D-0277-2025 Class II — Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Di (March 5, 2025)
  • D-0190-2025 Class II — Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 co (December 30, 2024)
  • D-0188-2025 Class II — Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) an (December 30, 2024)
  • D-0189-2025 Class II — Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distri (December 30, 2024)
  • D-0105-2025 Class II — Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distr (November 19, 2024)
  • D-0107-2025 Class II — Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count ND (November 19, 2024)
  • D-0106-2025 Class II — Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), (November 19, 2024)
  • D-0599-2024 Class III — Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Lab (June 24, 2024)